UK says vaccine manufacturing is 'lumpy' but still on course for targets
Britain's vaccine rollout is limited by a "lumpy" manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment Minister Nadhim Zahawi said on Monday. Ciara Lee reports
UP NEXT
NOW PLAYING: lifestylegeneral
UK says vaccine manufacturing is 'lumpy' but still on course for targets
Reuters
UP NEXT
-
New U.S. COVID-19 cases hit plateau after steep drops
Reuters
-
Global COVID-19 infections up for first time in seven weeks, WHO says
-
More than 20 million in Britain get first COVID-19 vaccine dose
-
Fauci urges Americans to get any of the three COVID-19 vaccines available
-
Fauci urges Americans to get any of the three COVID-19 vaccines available
-
Exclusive: Mexico's president expected to ask Biden to share U.S. vaccines, say sources
-
"Things are tenuous," U.S. CDC says as downward trend in COVID-19 cases stalls
-
UK to prioritise next stage of COVID-19 vaccines by age, not job
-
Advisory panel says FDA should authorize Johnson & Johnson COVID-19 vaccine
-
FDA advisory panel to review Johnson & Johnson COVID-19 vaccine with thumbs up expected
-
Advisory panel unanimously recommends FDA authorize Johnson & Johnson COVID-19 vaccine
-
UK lowers COVID-19 alert status as pressure on hospitals eases
-
Wanted: More high-tech manufacturing space for a global vaccine push
-
In boost for COVID-19 battle, Pfizer vaccine found 94% effective in real world
-
White House to roll out Johnson & Johnson vaccine doses next week, pending authorization
-
Biden administration to distribute more than 25 million masks
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A1D1282D23A3E61B92A788D3C3B8960D5%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%2721969d3d-90b1-4c3e-ab69-1b5ec502d197%27&-ver=%271.0%27&-impressionGuid=%2721969d3d-90b1-4c3e-ab69-1b5ec502d197%27&-pageName=%27channelplayerpage%27&-uri=%27http%253A%252F%252Fwww.msn.com%252Fen-au%252Flifestyle%252Flifestylegeneral%252Fuk-says-vaccine-manufacturing-is-lumpy-but-still-on-course-for-targets%252Fvp-BB1cRemg%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"video"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"21969d3d90b14c3eab691b5ec502d197"%2C"clid"%3A"1D1282D23A3E61B92A788D3C3B8960D5"%2C"clidType"%3A"muid"%2C"di"%3A"19552"%2C"partner"%3A"Reuters"%2C"publcat"%3A"Reuters%2BNews%2B%2526%2BMedia%2BInc."%2C"cvs"%3A"Browser"%2C"subcvs"%3A"lifestyle"%2C"entityId"%3A"BB1cRemg"%2C"entitySrc"%3A"vp"%2C"provid"%3A"AAf3a78"%2C"dpt"%3A"lifestylegeneral"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-au%27){kind=small}